
Spotify CEO Daniel Ek is advocating for Congress to implement an antitrust bill that would limit the sway of dominant app companies, reported the Hill. The CEO and founder of an audio streaming app is scheduled to meet with important members of Congress and the Biden administration on Wednesday and Thursday to advocate for legislation and renew support for the proposal. This marks his first visit to D.C. for this purpose.
“Left unchecked, any company doing business through an app store lives and dies at the mercy of whomever is the gatekeeper at the time,” Ek said in a blog post published Wednesday.
“It’s like leasing retail space from one of the few landlords in town who can charge a huge rent, change any term of the lease at any moment’s notice, place its own competing store right next to yours, and then prohibit you from sharing any promotional signs or advertisements that may reveal cheaper prices to customers or any benefits that would enhance their experience in any other location,” he added.
Ek is advocating for the passage of the Open App Markets Act in Congress, which made progress in the Senate and House Judiciary committees during the previous Congress but was not voted on.
The proposed bill seeks to regulate dominant app stores, specifically those operated by Apple and Google. This includes restricting fees for certain in-app purchases and mandating that apps only use one app store on their operating systems.
Featured News
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas